In terms with Regulation 30 read with Schedule III and other applicable provisions of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, (SEBI Listing Regulations, 2015), Blue Jet Healthcare has informed that, the Board of Directors of the Company at their meeting held through physical mode at its Registered Office on Tuesday, February 6, 2024, have approved the Un-Audited Standalone Financial Results for the Third Quarter and Nine Months ended December 31, 2023. It has enclosed Unaudited Standalone Financial Results for the Third Quarter and Nine Months ended December 31, 2023 along with the Limited Review Report thereon, issued by the Statutory Auditors of the Company. The meeting commenced at 12:00 pm and concluded at 1:45 pm.
The above information is a part of company’s filings submitted to BSE.
